(Q73061972)
Statements
The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro (English)
C Lövdahl
J Thyberg
A Hultgârdh-Nilsson
1 September 2000